Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 29, 2026 FORM 4
144 Jun 29, 2026
4 Jun 26, 2026 FORM 4
144 Jun 26, 2026
144 Jun 25, 2026
144 Jun 24, 2026
4 Jun 23, 2026 FORM 4
4 Jun 23, 2026 FORM 4
4 May 22, 2026 FORM 4
4 May 22, 2026 FORM 4
144 May 22, 2026
S-8 May 20, 2026 FORM S-8
10-K May 20, 2026 10-K
8-K May 20, 2026 8-K
SCHEDULE 13G/A May 12, 2026
SCHEDULE 13G/A May 6, 2026
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 22, 2026 FORM 4
4 Apr 21, 2026 FORM 4
4 Apr 21, 2026 FORM 4
4 Apr 21, 2026 FORM 4
4 Apr 20, 2026 FORM 4
144 Apr 20, 2026
144/A Apr 16, 2026
← Newer Page 4 of 40 · 994 filings Older →